Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
---|---|---|---|---|
ICRA | 446.11 | 152.24 | 223.73 | MAR, 2024 |
CARE Ratings | 331.68 | 102.56 | 158.82 | MAR, 2024 |
CRISIL | 3,139.52 | 658.44 | 975.14 | DEC, 2023 |
Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
---|---|---|---|---|---|---|---|
CRISIL | 41,606.10 | -1.20 | 62.14 | 18.32 | 13.17 | 46.18 | 0.95 |
ICRA | 6,042.88 | -1.19 | 39.95 | 6.24 | 13.20 | 40.36 | 1.60 |
CARE Ratings | 3,913.37 | -0.63 | 34.22 | 5.17 | 11.71 | 34.92 | 1.37 |